RecruitingNCT00985049

TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)

Whole Genome Expression of Left Ventricular Myocardium During Cardiac Surgery


Sponsor

Brigham and Women's Hospital

Enrollment

350 participants

Start Date

Mar 1, 2009

Study Type

OBSERVATIONAL

Conditions

Summary

Hypothesis: The investigators hypothesize that genetic variants will alter gene expression in response to ischemia during cardiopulmonary bypass. To test this, the investigators will be taking small pieces of heart tissue from patients undergoing heart surgery before and after this period of ischemia. This will be compared to blood gene expression in blood cells and analyzed with the patients' genetic profile. This might allow us to assess the amount of inflammation that occurs when patients are on the heart-lung machine as well as examine the effects genes have on this critical time period.


Eligibility

Min Age: 20 Years

Inclusion Criteria3

  • Aged greater than 20 years
  • Undergoing aortic valve surgery with or without CABG surgery
  • Receive and apical vent as part of the surgery

Exclusion Criteria1

  • Will not receive an apical left ventricular vent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Brigham and Women's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00985049


Related Trials